Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CGP-59326 is an epidermal growth factor receptor (EGFR) antagonist, which is used in anti-cancer research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | CGP-59326 is an epidermal growth factor receptor (EGFR) antagonist, which is used in anti-cancer research. |
Synonyms | UNII-YP9UZR062O, CGP59326, CGP 59326, TRX-13 |
Molecular Weight | 272.73 |
Formula | C14H13ClN4 |
CAS No. | 173458-56-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CGP-59326 173458-56-5 UNII-YP9UZR062O CGP59326 CGP 59326 TRX-13 TRX 13 TRX13 inhibitor inhibit